Advisors Preferred’s Bio-Techne TECH Stock Holding History

Advisors Preferred’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,536	Closed	-$318K	–	256
2017 Q3	$318K	Buy	+10,536	New	+$313K	0.18%	60

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Advisors Preferred's TECH Position: Q4 2017 in Review

Advisors Preferred sold out of Bio-Techne (TECH) in Q4 2017, closing a stake of 10,536 shares — an estimated $318K sold.

Advisors Preferred first reported a position in TECH in Q3 2017 and held it in 1 quarter. The position peaked at $318K in Q3 2017. 297 funds tracked by Wall St. Rank hold TECH as of Q4 2017.

Advisors Preferred reported no remaining Bio-Techne position as of Q4 2017 after selling out during the quarter.
Advisors Preferred sold 10,536 Bio-Techne shares in Q4 2017, an estimated $318K.
Advisors Preferred first reported a position in Bio-Techne in Q3 2017 and held it in 1 quarter.
Advisors Preferred's Bio-Techne position peaked at $318K in Q3 2017.
297 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2017.

Based on Advisors Preferred's 13F filing for Q4 2017, filed 12 Feb 2018.